HISTORY OF OUTCOME MEASURES FOR MYASTHENIA GRAVIS

被引：40
|
作者：
Burns, Ted M. [1 ]
机构：
[1] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA
来源：
MUSCLE & NERVE | 2010年 / 42卷 / 01期
关键词：
myasthenia gravis; outcome measures; MG Composite; MG-QOL15; rating scales; QUALITY-OF-LIFE; SELF-ADMINISTERED QUESTIONNAIRE; ALTERNATE-DAY PREDNISONE; LONG-TERM CORRELATION; MYCOPHENOLATE-MOFETIL; DOUBLE-BLIND; INTRAVENOUS IMMUNOGLOBULIN; ACETYLCHOLINE-RECEPTORS; RANDOMIZED-TRIAL; CLINICAL-TRIAL;
D O I：
10.1002/mus.21713
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
This review illustrates how measurements of clinical status in patients with myasthenia gravis have evolved from clinical descriptions and estimates of mortality rates to more sophisticated evaluative instruments, including numerical rating scales that measure strength, endurance, quality of life, and activities of daily living. The rationale and use of weighting and the importance of patient-reported outcomes are also discussed. The measurement of the steroid-sparing effect of an immunosuppressant is also reviewed. Muscle Nerve 42: 5-13, 2010
引用
收藏
页码：5 / 13
页数：9
相关论文
共 50 条
  • [1] Update in myasthenia gravis outcome measures
    Barnett-Tapia, Carolina
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [2] Evaluation of outcome measures for myasthenia gravis subgroups
    Luo, Yien
    Dong, Xiaohua
    Peng, Yuyao
    Cui, Biqi
    Yan, Chengkai
    Jin, Wanlin
    Li, Yi
    Zhou, Ran
    Huang, Kun
    Yang, Huan
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 91 : 270 - 275
  • [3] Surrogate therapeutic outcome measures in patients with myasthenia gravis
    Zinman, Lorne
    Baryshnik, Devra
    Bril, Vera
    MUSCLE & NERVE, 2008, 37 (02) : 172 - 176
  • [4] Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis
    Thomsen, Jan Lykke Scheel
    Andersen, Henning
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [5] Outcome measures and treatment effectiveness in late onset myasthenia gravis
    Francesca Pasqualin
    Silvia V. Guidoni
    Mario Ermani
    Elena Pegoraro
    Domenico M. Bonifati
    Neurological Research and Practice, 2
  • [6] Outcome measures and treatment effectiveness in late onset myasthenia gravis
    Pasqualin, Francesca
    Guidoni, Silvia V.
    Ermani, Mario
    Pegoraro, Elena
    Bonifati, Domenico M.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2020, 2 (01):
  • [7] COMPARISON OF OUTCOME MEASURES FROM A TRIAL OF MYCOPHENOLATE MOFETIL IN MYASTHENIA GRAVIS
    Wolfe, Gil I.
    Barohn, Richard J.
    Sanders, Donald B.
    McDermott, Michel P.
    MUSCLE & NERVE, 2008, 38 (05) : 1429 - 1433
  • [8] Serum metabolomics differentiates treatment response of myasthenia gravis clinical outcome measures
    Kaminski, H.
    Yaoxiang, L.
    Cheema, M.
    Wolfe, G.
    Kusner, L.
    Aban, I.
    Sikorski, P.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S79 - S79
  • [9] THE HISTORY OF MYASTHENIA-GRAVIS
    PASCUZZI, RM
    NEUROLOGIC CLINICS, 1994, 12 (02) : 231 - 242
  • [10] A history of treatments for myasthenia gravis
    Keesey, JC
    SEMINARS IN NEUROLOGY, 2004, 24 (01) : 5 - 16
12345